LGC AXIO Proficiency Testing Schemes 2027
Therapeutic Drugs Sample Code
Matrix
Analytes
PT-TM-TD01
3 x 5ml samples of lyophilised human serum
Carbamazepine; CBZ-epoxide; Carbamazepine + CBZ-epoxide; Clonazepam; Lamotrigine; Phenytoin; Ethosuximide; Phenobarbitone; Primidone; Valproate; Caffeine; Digoxin; Lithium; Theophylline; Methotrexate; Paracetamol (Acetaminophen); Salicylic Acid; TD-Amikacin; TDGentamicin; TD-Tobramycin; TD-Vancomycin
Other Therapeutic Drugs Sample Code Matrix
Analytes
PT-TM-AE01
1 x 4ml sample of lyophilised human serum
OH-oxcarbazepine; Gabapentin; Tiagabine; Levetiracetam; Pregabalin Topiramate; Vigabatrin; Felbamate; Zonisamide; Rufinamide; Lacosamide
PT-TM-AE02
1 x 4ml sample of lyophilised human serum
PT-TM-AE04 PT-TM-AE05 PT-TM-AE6 PT-TM-AE7 PT-TM-AM01
1 x 2ml sample of lyophilised human serum 1 x 2ml sample of lyophilised human serum 1 x 2ml sample of lyophilised human serum 1 x 2ml sample of lyophilised human serum 2 x 5ml sample of lyophilised human serum 2 x 2ml samples of lyophilised human serum 1 x 2ml sample of lyophilised human serum
Perampanel Brivaracetam
Stiripentol Sulthiame
Ibuprofen; Diclofenac; Tramadol; O-Desmethyltramadol
PT-TM-CN01
Clobazam; Norclobazam
PT-TM-CRD Cardiac mixture
Amiodarone; Desethylamiodarone; Flecainide
Drugs for Treatment of substance related disorders Sample Code Matrix
Analytes
PT-TM-SA01 Drugs for the Treatment of substance related disorders 1 PT-TM-SA02 Drugs for the Treatment of substance related disorders 2
2 x 2ml lyophilised human serum
Buprenorphine; Norbuprenorphine
2 x 2ml lyophilised human serum
Methadone; EDDP
Anti-Hypertensive Drug Screen Sample Code Matrix
Analytes
PT-TM-SA01 Drugs for the Treatment of substance related disorders 1
2 x 2ml lyophilised human serum
Buprenorphine; Norbuprenorphine
Chemotherapy Drugs Sample Code Matrix
Analytes
PT-TM-5FU
2 x 5ml lyophilised human plasma
5-Fluorouracil
Download Application Form
Download Scheme Description
lgcstandards.com/AXIO-PT 115
Made with FlippingBook Ebook Creator